F. Collins, “The real promise of mobile health apps,” Scientific American, vol. 307, no. 1, p. 16, 2012.
[2]
Vital Wave Consulting, mHealth for Development: The Opportunity of Mobile Technology for Healthcare in the Developing World, UN Foundation-Vodafone Foundation Partnership, Berkshire, UK, 2009.
[3]
R. P. Westergaard, T. Hess, J. Astemborski, S. H. Mehta, and G. D. Kirk, “Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users,” AIDS, vol. 27, no. 16, pp. 2559–2566, 2013.
[4]
G. M. Lucas, K. A. Gebo, R. E. Chaisson, and R. D. Moore, “Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic,” AIDS, vol. 16, no. 5, pp. 767–774, 2002.
[5]
F. L. Altice, A. Kamarulzaman, V. V. Soriano, M. Schechter, and G. H. Friedland, “Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs,” The Lancet, vol. 376, no. 9738, pp. 367–387, 2010.
[6]
A. Labrique, L. Vasudevan, L. W. Chang, and G. Mehl, “H_pe for mHealth: more, “y” or, “o” on the horizon?” International Journal of Medical Informatics, vol. 82, no. 5, pp. 467–469, 2013.
[7]
T. Horvath, H. Azman, G. E. Kennedy, and G. W. Rutherford, “Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD009756, 2012.
[8]
S. Kumar, W. J. Nilsen, A. Abernethy, et al., “Mobile health technology evaluation: the mHealth evidence workshop,” The American Journal of Preventive Medicine, vol. 45, no. 2, pp. 228–236, 2013.
